LBCA invites you to view the recording of the first session of a four part series on liquid biopsy/CtDNA tests and relevance for ILC.
In this first session, clinician/researcher Dr. Julia Foldi, breast medical oncologist at UPMC Hillman Cancer Center, discusses topics including: when these tests may be useful in ILC treatment, what can and can’t yet be concluded from the test results for ILC patients, and how some clinicians are using these tests in treatment of ILC patients to complement imaging and other tests.
The Q&A portion is facilitated by LBCA Research Advocate, Janet Axelrod.